The COVID-19 pandemic era is shaking up the pharma supply chain. Heavily regulated processes that used to take years are speeding up as existing drugs are repurposed as therapeutics for COVID-19 patients, and new drugs and vaccines are under development. Gurdip Singh, CEO at Kallik, provides a health check for pharma businesses who are straining every sinew to meet changing market demands.